中国癌症防治杂志2025，Vol.17Issue(6)：683-689,7.DOI:10.3969/j.issn.1674-5671.2025.06.05
2025年度前列腺癌临床诊疗进展
Advances in the clinical diagnosis and treatment of prostate cancer in 2025
摘要
Abstract
In recent years,the incidence and mortality rates of prostate cancer in China have continued to rise,leading to an increased disease burden.The widespread adoption of precision medicine principles,coupled with advancement of drug research,has significantly transformed the management of prostate cancer at each stage.This article systematically reviews and summarizes the key clinical research progress in 2025 around three major themes:the innovation of precision diagnosis and treatment for localized prostate cancer,the forward-moving of intensified treatment and precision stratification for metastatic hormone-sensitive prostate cancer(mHSPC),and the breakthrough of new mechanism for metastatic castration-resistant prostate cancer(mCRPC).关键词
前列腺癌/精准诊疗/新型内分泌治疗/生物标志物Key words
Prostate cancer/Precision diagnosis and treatment/Novel hormone therapy/Biomarkers分类
医药卫生引用本文复制引用
曾斌,徐航,廖鑫扬,涂祥,李佳坤,魏强,杨璐..2025年度前列腺癌临床诊疗进展[J].中国癌症防治杂志,2025,17(6):683-689,7.基金项目
国家自然科学基金项目(82372831) （82372831）
